ImPact enters partnership for pathologic myopia therapy development
ImPact Biotech entered into a partnership with Maastricht University to develop a therapy for arresting pathologic myopia progression.
ImPact Biotech entered into a partnership with Maastricht University to develop a therapy for arresting pathologic myopia progression.
What's Your Reaction?
